EAU 2017 | Survivorship in high risk localized prostate cancer

Bertrand Tombal, MD, PhD, Catholic University of Leuven, Leuven, Belgium, discusses survivorship at the European Association of Urology (EAU) conference 2017 in London, UK. Survivorship is often confused with overall survival, however it is instead the quality of life of survivors. The prognosis for high risk localized prostate cancer is very good, with approximately 90 to 95% surviving for 10 years or more. Despite being in a durable remission, there may be physical, emotional, and socio-economic consequences from treatment. Therefore there needs to be a switch in attention between those who survive, and how they can be helped, compared to the comparatively small minority of individuals that die.